Bio-Techne
TECH
369 hedge funds and large institutions have $7.5B invested in Bio-Techne in 2019 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 121 increasing their positions, 132 reducing their positions, and 36 closing their positions.
47% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 36
6% more capital invested
Capital invested by funds: $7.07B → $7.5B (+$436M)
4% more funds holding
Funds holding: 356 → 369 (+13)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.77% less ownership
Funds ownership: 377% → 376.23% (-0.77%)
8% less repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 132
89% less call options, than puts
Call options by funds: $438K | Put options by funds: $4.09M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$106M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$25M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$21.4M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$12.9M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MPI
Mairs & Power Inc
St Paul,
Minnesota
|
-$17.3M |
| 2 |
Millennium Management
New York
|
-$17M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$10.2M |
| 4 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$10.2M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$9.97M |
TECH Hedge Fund Activity: Q2 2019 in Review
369 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2019, worth a combined $7.5B — up 6.2% from $7.07B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new TECH positions and 36 closed out — a net gain of 17 holders — while 121 added to existing stakes and 132 trimmed.
The largest buyer was Invesco, adding an estimated $106M. The largest seller was Mairs & Power Inc, cutting an estimated $17.3M.
- 369 institutional investors held Bio-Techne (TECH) as of Q2 2019, up from 356 in Q1 2019.
- Funds reported $7.5B of Bio-Techne stock for Q2 2019, up 6.2% quarter-over-quarter.
- 53 funds opened new Bio-Techne positions in Q2 2019 and 36 closed out, a net change of +17 holders.
- The largest Bio-Techne buyer in Q2 2019 was Invesco, an estimated $106M added.
- The largest Bio-Techne seller in Q2 2019 was Mairs & Power Inc, an estimated $17.3M sold.
Based on aggregated 13F filings for Q2 2019.